|
SNW1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.760400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.886200E-01 |
| Normal-vs-Stage2 |
1.345770E-01 |
| Normal-vs-Stage3 |
3.244600E-03 |
| Normal-vs-Stage4 |
9.183600E-01 |
| Stage1-vs-Stage2 |
4.072100E-02 |
| Stage1-vs-Stage3 |
8.2201000000004E-05 |
| Stage1-vs-Stage4 |
9.613400E-01 |
| Stage2-vs-Stage3 |
4.113600E-01 |
| Stage2-vs-Stage4 |
4.778000E-01 |
| Stage3-vs-Stage4 |
2.796800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.819400E-01 |
| Normal-vs-AfricanAmerican |
4.970600E-01 |
| Normal-vs-Asian |
2.839200E-01 |
| Caucasian-vs-AfricanAmerican |
8.265200E-01 |
| Caucasian-vs-Asian |
5.272000E-01 |
| AfricanAmerican-vs-Asian |
3.284200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.459200E-01 |
| Normal-vs-Female |
7.303200E-01 |
| Male-vs-Female |
6.208800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.923000E-01 |
| Normal-vs-Age(41-60Yrs) |
6.574000E-01 |
| Normal-vs-Age(61-80Yrs) |
7.260000E-02 |
| Normal-vs-Age(81-100Yrs) |
5.775600E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.072600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.310800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.058600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.441600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.432300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.973000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.88399999998279E-06 |
| Normal-vs-Grade 2 |
3.795600E-01 |
| Normal-vs-Grade 3 |
2.863100E-03 |
| Normal-vs-Grade 4 |
8.650400E-01 |
| Grade 1-vs-Grade 2 |
6.606700E-04 |
| Grade 1-vs-Grade 3 |
3.8149000003429E-07 |
| Grade 1-vs-Grade 4 |
1.988430E-02 |
| Grade 2-vs-Grade 3 |
2.46989999996838E-06 |
| Grade 2-vs-Grade 4 |
6.906600E-01 |
| Grade 3-vs-Grade 4 |
5.357200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.986370E-01 |
| Normal-vs-ccB subtype |
6.995000E-03 |
| ccA subtype-vs-ccB subtype |
3.3566999999568E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.896600E-01 |
| Normal-vs-N1 |
1.584670E-03 |
| N0-vs-N1 |
1.781980E-02 |
|
|
